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Abstract
Recent studies have suggested a link between particulate matter (PM) exposure and increased mortality and morbidity
associated with pulmonary and cardiovascular diseases; accumulating evidences point to a new role for air pollution in CNS
diseases. The purpose of our study is to investigate PM10sum effects on lungs and extra pulmonary tissues. Milano
PM10sum has been intratracheally instilled into BALB/c mice. Broncho Alveolar Lavage fluid, lung parenchyma, heart and
brain were screened for markers of inflammation (cell counts, cytokines, ET-1, HO-1, MPO, iNOS), cytotoxicity (LDH, ALP,
Hsp70, Caspase8-p18, Caspase3-p17) for a putative pro-carcinogenic marker (Cyp1B1) and for TLR4 pathway activation.
Brain was also investigated for CD68, TNF-a, GFAP. In blood, cell counts were performed while plasma was screened for
endothelial activation (sP-selectin, ET-1) and for inflammation markers (TNF-a, MIP-2, IL-1b, MPO). Genes up-regulation
(HMOX1, Cyp1B1, IL-1b, MIP-2, MPO) and miR-21 have been investigated in lungs and blood. Inflammation in the respiratory
tract of PM10sum-treated mice has been confirmed in BALf and lung parenchyma by increased PMNs percentage, increased
ET-1, MPO and cytokines levels. A systemic spreading of lung inflammation in PM10sum-treated mice has been related to
the increased blood total cell count and neutrophils percentage, as well as to increased blood MPO. The blood-endothelium
interface activation has been confirmed by significant increases of plasma ET-1 and sP-selectin. Furthermore PM10sum
induced heart endothelial activation and PAHs metabolism, proved by increased ET-1 and Cyp1B1 levels. Moreover,
PM10sum causes an increase in brain HO-1 and ET-1. These results state the translocation of inflammation mediators,
ultrafine particles, LPS, metals associated to PM10sum, from lungs to bloodstream, thus triggering a systemic reaction,
mainly involving heart and brain. Our results provided additional insight into the toxicity of PM10sum and could facilitate
shedding light on mechanisms underlying the development of urban air pollution related diseases.
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Introduction
Short term exposure to a high amount of PM10 (particles
#10 mm in aerodynamic diameter, including fine and ultrafine
particles) leads to higher hospitalization rates for cardiovascular
diseases, increases risk for myocardial infarction and ischemic
stroke [1], even 24 h after peak of pollution [2]. Different possible
mechanisms have been hypothesized to explain the systemic effect
of PM inhalation [3,4]: on one hand, the inhaled PM may trigger
the direct release of pro-oxidative and/or pro-inflammatory
mediators from lungs into systemic circulation and, on the other
hand, ultrafine PM may actively translocate from lungs into the
bloodstream thus exerting extra pulmonary toxicity.
Convincing evidences indicate that PM10 causes the most
severe effects on human health because of the broad range of
miscellaneous toxic compounds present in this PM fraction [1,3],
such as transition metals, endotoxins [5] and ultrafine compo-
nents, which could mediate the adverse effects in a mechanism
called the ‘‘ultrafine hypothesis’’ [6].
Brain is another potential target of the inhaled PM: it is known
that inhaled nanosized particles can penetrate lungs, deposit in
extra pulmonary tissues and cross the blood-brain barrier (BBB),
possibly already compromised by the PM triggered systemic
inflammation [7].
Our previous investigations [8] demonstrated that summer
PM10 (PM10sum) induced more severe lung inflammation than
winter PM10 (PM10win) after a single intratracheal instillation in
mice, and suggested a link between pro-inflammogenic potential of
PM10sum and its Gram-negative bacteria content [9]. The greater
LPS amount associated to PM10sum (60,5 EU/mg) [10] could
induce in lungs a condition that might trigger a systemic toxic
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reaction, so that the aim of the present study is to broaden the
analysis of Milano PM10sum-induced toxicity, not only in the
respiratory tract but also in extra pulmonary districts. To disclose
the systemic toxicity of Milano PM10sum, we here analysed
different pro-inflammatory and cytotoxic markers, both at RNA as
well as at protein level, in BALB/c mice broncho-alveolar lavage
fluid (BALf), lungs, blood, heart and brain, 24 hours after the last
of three intratracheal instillations of PM10sum. Finally we
evaluated the microRNA miR-21, recently proposed as a new
marker of inflammation which is up-regulated by LPS in many
cells types, including macrophages [11].
Materials and Methods
Animals
Male BALB/c mice (7–8 weeks old) were purchased from
Harlan; food and water were administered ad libitum. Mice were
housed in plastic cages under controlled environmental conditions
(temperature 19–21uC, humidity 40–70%, lights on
7 a.m.27 p.m.). ‘‘Animal use and care procedures were approved
by the Institutional Animal Care and Use Committee of the
University of Milano-Bicocca and complied with guidelines set by
Italian Ministry of Health (DL 116/92); invasive procedures have
been performed under anesthesia and all efforts were made to
minimize suffering.’’
PM Sources and Characterization
Atmospheric PM10sum was collected during summer 2008 at
Torre Sarca, an urban site in Milano, as described in previous
papers [12]. The chemical characterization of PM10 collected
during summer 2008 doesn’t differ from the PM10 collected in
summer 2006 and 2007 [10]. Particles were recovered from filters
by sequential sonications (four cycles of 20 min each) in sterile
water; detached particles were dried into a desiccator and
weighed. Particles’ suspensions were prepared as follow: just
before the intratracheal instillation, PM10sum aliquots were
properly diluted in sterile saline, sonicated, vortexed and then
immediately instilled in mice.
Dose
A single intratracheal instillation of 100 mg of PM10sum raised
pulmonary inflammation within 3 hours; 24 h after the single
instillation all the inflammatory markers basically turned to sham
levels, and only differential cell count and Hsp70 reverted 1 week
later [8].
The aim of this study is to disclose the pulmonary short-term
effects and extra-pulmonary translocation of PM10sum collected
in Milano urban centre. Similar investigations have been pre-
viously based on very high PM exposure rate both in case of whole
chamber PM exposure [13,14,15,16,17,18,19] and in single or
repeated intratracheal instillations [20,21,22,23,24,25].
It is well known that larger particles in the lungs are rapidly
phagocytised by AMs while smaller particles enter the blood
capillaries [20]; moreover, pulmonary inflammation plays a key
role in enhancing the extra-pulmonary translocation of particles,
as confirmed by the evidence that particles translocation is
markedly increased following LPS treatment [20]. We have
previously reported that LPS concentration is particularly high in
PM10sum collected in Milano (60 EU/mg) [10] and that
PM10sum sub-fraction contains about 60% of fine and ultrafine
particles [26]. Our treatment scheme has been designed to
lengthen the PM10sum triggered pro-inflammatory effects within
lungs, in order to prove the translocation of inflammatory
mediators, cytokines, ultrafine particles, LPS and/or PM associ-
ated metals from lungs toward the bloodstream. We started from
the PM dose proposed by Happo et al. [24], who instilled in mice
a cumulative dose of 0.82 mg/animal of coarse PM, and we
reduced the cumulative dose to 0.3 mg/animal of PM10sum
within the same time points. Indeed, the PM dose here used is not
directly correlated to human urban exposures, but it has been
determined as the lowest dose which induces a sustained lung
inflammatory response in PM10sum exposed mice.
It must be taken into account that not all the particles
intratracheally instilled are able to reach the alveoli, as some are
quickly removed by the muco-ciliar clearance system or
phagocited by alveolar macrophages. Finally, we used healthy
BALB/c mice, preventing additional variability to response due to
pre-existing disease. In any case, no signs of PM10sum lung
overloading have been reported as clearly demonstrated by
histological and biochemical investigations.
Intratracheal PM10sum Instillation
Animal testing was carried out by intratracheally instilling 3
mice for each experimental group and the experiment was
replicated twice, for a total of 6 sham and 6 PM10sum-treated
mice. For RNA and miRNA analysis, additional 5 sham and 5
PM10sum-treated mice were considered.
Male BALB/c mice were briefly exposed to a mixture of 2.5%
isoflurane (Flurane) anesthetic gas and kept under anaesthesia for
the whole instillation procedure (about 5 minutes). Intratracheal
instillation with 100 mg of PM10sum in 100 ml of isotonic saline
solution or 100 ml of isotonic saline solution (sham) has been
achieved by means of MicroSprayerH Aerosolizer system (Micro-
SprayerH Aerosolizer- Model IA-1C and FMJ-250 High Pressure
Syringe, Penn Century, USA; validated by Bivas-Benita [27], as
described in Mantecca et al. [28,29] and in Farina et al. [8]. The
intratracheal instillation was performed on days 0, 3, and 6, for
a total of three instillations, as previously described [24,25].
Bronchoalveolar Lavage Fluid Analysis
24 h after the last instillation, mice from each experimental
group (sham and PM10sum-treated) were euthanized with an
anesthetic mixture overdose (Tiletamine/Zolazepam-Xylazine
and Flurane). The PM adverse effects were assessed 24 h after
the last treatment of repeated dosing of particulate since the
greatest and prolonged inflammation does occur within this time
point [24]. The Broncho Alveolar Lavage Fluid (BALf), pellets and
supernatants have been collected as described in Mantecca et al.
[28,29] and in Farina et al. [8].
Cell counts. After centrifugation, total and differential cell
counts were performed according to Mantecca et al. [28,29] and
Farina et al. [8].
Cytokines analysis. The analysis of pro-inflammatory
cytokines and chemokines released in the BALf was performed
by DuoSet ELISA kits for TNF-a, MIP-2 and IL-1b(R&D
Systems, Minneapolis, MN) according to the manufacturer’s
protocols.
Biochemical analysis. The following biochemical analysis
were performed on cell-free BALf supernatants. The commercially
available kits for ALP (DALP-250 QuantiChrom Alkaline
Phosphatase Assay Kit, Gentaur Molecular) and LDH (DLDH-
100 QuantiChrom Lactate Dehydrogenase Kit, Gentaur Molec-
ular) were employed according to the manufacturer’s instructions.
Other proteins. 30 mg of BALf proteins of sham and
PM10sum-treated mice were loaded on SDS-PAGE, submitted
to electrophoresis followed by Western blot, and tested for MPO
and Hsp70 (anti-MPO 1:200, anti-Hsp70 1:200, Santa Cruz),
according to the procedures below described.
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Lung, Heart and Brain Parenchyma Analysis
Lungs of sham and PM10sum-treated mice were quickly excised
from the chest and washed in ice cold isotonic saline solution. Left
lung from sham and PM10sum-treated mice was dissected and
submitted to histological and immunohystochemical analysis,
while right lung was submitted to immunoblotting analysis. For
proteins detection and quantification, organs were minced at 4uC,
briefly homogenized for 30 seconds at 11000 rpm with Ultra-
Turrax T25 basic (IKA WERKE), sonicated for 30 seconds and
then suspended in NaCl 0.9%. Samples were submitted to
trichloroacetic acid (TCA) precipitation according to the pro-
cedure described in Farina et al. [8]. The pellets were suspended
in water and protein amounts measured by BCA method (Sigma
Aldrich, USA).
Thereafter, lung, heart and brain homogenates of sham and
PM10sum-treated mice were loaded on SDS-PAGE and sub-
mitted to electrophoresis, followed by Western blot, according to
the procedures described in Farina et al. [8]. Lung parenchyma
was assessed with specific antibodies for MPO, ET-1, HO-1,
Cyp1B1, iNOS, Hsp70, Caspase8-p18 and Caspase3-p17 (all
1:200, Santa Cruz). The activation of TLR4 pathway has been
studied by investigating the phosphorylation of IRAK-1, TAK1
and IKBa (all 1:200, Abcam). Heart homogenates were incubated
with specific antibodies for MPO, HO-1, Hsp70, Cyp1B1, ET-1
Caspase8-p18 and Caspase3-p17 (all 1:200, Santa Cruz) and brain
homogenates were evaluated with specific antibodies for ET-1,
HO-1, soluble and membrane bound TNF-a, Hsp70, Cyp1B1,
CD68, GFAP, Caspase8-p18 and Caspase3-p17 (all 1:200, Santa
Cruz).
Then, blots were incubated for 1.5 h with horseradish
peroxidase-conjugated anti-rabbit IgG (1:5000) or anti-goat IgG
(1:2000) diluted in PBS-Tween20/milk or in TBS-Tween20/BSA.
Proteins were detected by ECL by means of the SuperSignal
detection kit (Pierce, Rockford, IL). Immunoblot bands were
analyzed and the optical density (OD) quantified by KODAK
(Kodak Image Station 2000R); all the data have been normalized
to b-actin (1:1500, Sigma) and each protein in PM10-treated
group has been normalized to the respective sham group.
Lung Histological Analysis
At the end of BAL procedure, the left lung from sham and
PM10sum-treated mice was excised and immediately formalin
fixed and processed for histology. Briefly, after being preserved for
24 h in the fixative, tissue samples were rinsed in distilled water,
dehydrated in an ethanol series from 70% to 100% and embedded
in Bio-plast tissue embedding medium. For each sham and
PM10sum exposed lung sample, 7.0 mm serial sections were cut by
a rotary microtome, mounted on slides and stained with Mayer’s
haemalaun and alcoholic eosin.
The immunohistochemical localization of HO-1 in lung tissues
was performed by an indirect immunochemical method using
a rabbit anti-HO-1 polyclonal antibody (Santa Cruz), and the
peroxidase-based Vectastain Elite ABC Kit (Vectastain Laborato-
ries) following the procedure reported in Mantecca et al. [29].
Samples were qualitatively screened by means of Zeiss Axioplan
microscope at a magnification of 406and images were taken using
Zeiss AxioCam MRc5 digital camera interfaced with the
Axiovision Real 4.6 software. Figure panels were prepared using
Adobe Photoshop.
Blood Analysis
Blood of sham and PM10sum-treated mice was collected by
means of intracardiac puncture with the appropriate anticoag-
ulant (EDTA, Na-citrate). Total cells count and neutrophils
percentage were performed as previously described [8]. Plasma
was obtained after two centrifugation, the first at 2000 g for 20
minutes and the second at 10000 g for 10 minutes at 4uC to
completely remove platelets. Plasma samples have been then
submitted to sP-Selectin quantification (Quantikine Mouse sP-
selectin, R&D Systems) and cytokines analysis (TNF-a, MIP-2
and IL-1b; R&D Systems, Minneapolis, MN), following
manufacturer’s procedures. Immunoblot assays of MPO and
ET-1 (all 1:200, Santa Cruz) were performed according to
previously described protocols; all the data have been normal-
ized to albumin. Each protein of PM10sum-treated group has
been normalized to the respective sham group.
RNA e miRNA Expression Analysis
5 sham and 5 PM10sum-treated mice were considered for
RNA analysis. Lungs, not submitted to BAL procedure (called
‘‘no-BAL’’), have been excised, suspended in an appropriate
volume of RNA Later and submitted to total RNA extraction.
Aliquots of lung and heart parenchyma from all the 5 sham and
5 PM10sum-treated mice were submitted to immunoblot
analysis. Total RNA was extracted from tissues using the
miRNeasy extraction kit (Qiagen, Hilden, Germany), according
to the manufacturer’s instructions. Blood sample collection and
RNA extraction were carried out using the Mouse RiboPureTM-
Blood RNA Isolation kit (Ambion, Life Technologies, Carlsbad,
CA, USA), following the manufacturer’s instructions. After
elution in RNase free-water, RNA samples were quantified by
ND-1000 spectrophotometer (NanoDrop Technologies, Wil-
mington, DE, USA). RNA quality was checked by micro-
capillary electrophoresis with 2100 BioAnalyzer (Agilent Tech-
nologies, Santa Clara, CA, USA). Total RNA integrity was
assessed on the basis of the RIN (RNA Integrity Number) factor
and presence of low molecular weight RNA molecules (in-
cluding 5S rRNA and small RNAs) was verified. RNA samples
were stored at 280uC until use.
Quantitative PCR (QPCR) reactions for microRNAs was
performed by use of TaqManH MicroRNA Reverse Transcription
(RT) kit (Applied Biosystems, Life Technologies, Inc. Carlsbad,
CA, USA) and of specific miRNA primers provided with
TaqManH microRNA assays, according to the manufacturer’s
protocol. Starting from 10 ng of total RNA for each assay, RT
reactions were performed by means of Applied Biosystems 7900
Thermocycler machine. Quantitative microRNA expression
analysis was carried out for miR-21 (Assay ID, 000397, Applied
Biosystems) normalized against U6snRNA (Assay ID, 001973,
Applied Biosystems) taken as endogenous control. For gene
expression analysis, we performed QPCR starting from 1 mg of
total RNA using the High Capacity cDNA Reverse Transcription
kit (Applied Biosystems) and gene-specific primers provided with
TaqManH Gene Expression Assays. Specifically, QPCR analysis
were carried out for HMOX1 (Assay ID Mm00516005_m1),
Cyp1B1 (Assay ID Mm00487229_m1), IL-1b (Assay ID
Mm01336189_m1), MIP-2 (Assay ID Mm00436450_m1) and
MPO (Assay ID Mm00447886_m1) genes. All data have been
normalized versus glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, Assay ID Mm99999915_g1) gene taken as endogenous
control. Reactions were run in triplicate on the Applied Biosystems
7900HT Fast Real-Time PCR System machine. Ct values were
calculated using the SDS software version 2.3 (Applied Biosys-
tems), by applying automatic baseline and standard threshold
settings. We applied the 22DDCt method (Applied Biosystems User
Bulletin No. 2) to obtain a relative quantification of miRNA and
gene expression levels.
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Statistical Analysis
For each cytological and biochemical parameter measured in
sham and PM10sum treated mice the means 6 standard error
(s.e.) were calculated. Statistical differences were confirmed by U
Mann-Withney test. To test the tendency toward increase or
decrease of the cytological and biochemical parameters, linear
regressions were carried out. Statistical differences were consid-
ered to be significant at the 95% or 99% level (p,0.05 or p,0.01).
Results
BALf Analysis
Total cell count confirmed no differences between sham and
PM10sum-treated mice, 24 h after the last PM10sum intratracheal
instillation (Tab. 1, A). On the contrary, differential cell count
disclosed a significant decrease of AMs percentage and a significant
increase of PMNs percentage (99% neutrophils) in treated mice
(Tab. 1, A). A significant increase of IL-1b and MIP-2
concentrations were evident in the BALf of PM10sum-treated
mice in comparison to sham, though in presence of unchanged
concentration of TNF-a (Tab. 1, A). Lactate Dehydrogenase
(LDH) and Alkaline Phosphatase (ALP) activities were analyzed in
the BALf as markers of cytotoxicity. LDH activity was significantly
increased in PM10sum-treated mice (Tab. 1, A), while no
difference was detected in ALP activity (Tab. 1, A). Finally,
PM10sum-treatment induced a significant increase in both MPO
and Hsp70 levels (Fig. 1, A and Tab. 1, B).
Lung Genes Expression Analysis
PM10sum-treatment induced a significant MIP-2 up-regulation
while no significant changes were found for HMOX1, Cyp1B1,
IL-1b and MPO; an induction of miR-21 in the lung tissues of
PM10sum-treated mice was evidenced during miRNA gene
expression analysis (Tab. 2).
Figure 1. BALf, lung, heart, brain and plasma immunoblotings. Western blottings displaying proteins in BALf (A), lung (B), heart (C), brain (D)
and plasma (E) in sham and PM10sum-treated mice, 24 h after the third intratracheal instillation. Reported blots are representative of 6 sham and 6
PM10sum-treated mice; densitometry analyses are reported in Tab.1.
doi:10.1371/journal.pone.0056636.g001
Table 1. BALf analysis.
BALf sham (n=6)
PM10sum
(n=6)
mean 6 s.e. mean 6 s.e. p
A Total cells (E+06) 5.21 1.34 5.93 2.31
AMs% 70.2 9.48 41.33 3.73 **
PMNs% 28.8 9.91 57.91 4.02 *
Ls% 0.97 0.97 0.68 0.68
TNF-a (pg/mL) 157.7 32.21 310.98 94.5
MIP-2 (pg/mL) 49.46 33.9 271.09 64.11 *
IL-1b (pg/mL) 40.63 17.46 164.35 36.39 *
LDH (IU/L) 30.7 2.46 43.43 4.46 *
ALP (IU/L) 0.37 0.11 0.36 0.07
B MPO 1 0.23 2.91 0.55 *
Hsp70 1 0.31 3.19 0.72 *
Several markers have been analysed in the BALf of sham and PM10sum-treated
mice. (A): table summarizing results of cell counts and biochemical analysis in
BALf from sham (n = 6) and PM10sum-treated mice (n = 6), 24 h after the third
intratracheal instillation; (B): immunoblotting results in BALf from sham (n = 6)
and PM10sum-treated mice (n = 6), 24 h after the third intratracheal instillation;
each protein in PM10-treated group has been normalized onto respective sham
group. All the data are expressed as mean 6 s.e. Sham vs PM10sum-treated:
*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0056636.t001
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Lung, Heart and Brain Protein Analyses
ET-1, a potent regulator of the vascular tone, was significantly
higher in the lungs of PM10sum-treated mice in comparison to
sham (Fig. 1, B and Tab. 3, A). Moreover a significant increase in
HO-1 and Hsp70 levels (Fig. 1, B and Tab. 3, A), both involved in
the protection against protein unfolding, as well as in the
inflammation and oxidative stress, were observed in the lungs of
PM10sum-treated mice. The level of Cyp1B1, a cytochrome of the
P450 superfamily involved in the activation of many xenobiotics
and in PAHs metabolism, significantly decreased 24 h after the
last PM10sum intratracheal instillation (Fig. 1, B and Tab. 3, A).
iNOS, MPO, Caspase8-p18 and Caspase3-p17 showed no
differences between sham and PM10sum-treated mice (Tab. 3,
A). TLR4 pathway was not activated as no increases of the
IRAK1, TAK1 and IKBa phosphorylation were detected (Tab. 3,
A).
Heart tissues of PM10sum-treated mice disclosed significant
increases of ET-1, Cyp1B1 and Hsp70 levels (Fig. 1, C and Tab. 3,
B). MPO, HO-1, Caspase8-p18 and Caspase3-p17 shown no
differences between sham and PM10sum treated mice (Tab. 3, B).
In the brain of PM10sum-treated mice, ET-1 and HO-1 levels
were significantly increased (Fig. 1, D and Tab. 3, C); Cyp1B1,
CD68, soluble and membrane bound TNF-a, Hsp-70, GFAP,
Caspase8-p18, Caspase3-p17 were basically unchanged compar-
ing sham and PM10sum-treated mice (Tab. 3, C).
Blood and Plasma Analysis
Gene expression analysis evidenced no up-regulation of
HMOX1 or IL-1b in blood RNA of PM10sum-treated mice,
compared to sham, together with no induction of miR-21 (Tab. 4).
Blood and plasma of sham and PM10sum-treated mice were
analysed for pro-inflammatory and pro-trombogenic markers.
Total cell count, neutrophils percentage and sP-selectin concen-
tration, a marker of the activated platelet/endothelium interface,
were significantly increased 24 h after the last intratracheal
instillation of PM10sum (Tab. 5, A). The cytokines analyses in
the plasma of sham and PM10sum-trated mice, performed by
ELISA assay, were under the kit detection limits.
Finally, both MPO and ET-1 increased in PM10sum-treated
mice (Fig. 1, E and Tab. 5, B).
Histopathological Findings
Despite the relatively high cumulative dose of PM10sum
instilled, there were no signs of pulmonary overloading with
particles; moreover, only few free particles and no large particle
aggregates were seen in the BALf or lung tissue of treated mice.
As evidenced by the histological lung analysis, when compared
to sham (Fig. 2, A–B) PM10sum has induced inflammatory cell
recruitment in the connective surrounding the terminal bronch-
ioles and the proximal alveolar sacs (Fig. 2, C–D). Lungs instilled
with PM10sum showed extended inflammatory infiltrate and
particles engulfed by alveolar macrophages (Fig. 2, C–D). These
histological evaluations have supported the cytological and
biochemical assays on BALf. Immunohistochemical detection of
HO-1 in the lungs of PM10sum-treated mice has confirmed the
biochemical analyses, (Fig. 3, A–D). HO-1 induction appeared to
be distributed along both airways and the respiratory tract,
particularly well distinguishable within the epithelium of distal
bronchioles (Fig. 3, C–D).
Table 2. Lung gene expression.
LUNG fold increase range 6 s.e. p
HMOX1 1.51 0.68–2.10 0.39
Cyp1B1 1.29 1.03–1.71 0.24
IL-1b 1.07 0.93–1.32 0.16
MIP-2 2.55 2.03–2.90 0.15 *
MPO 2.21 1.21–3.02 0.4
miR-21 3.04 1.47–5.55 0.59 *
QPCR gene expression analysis in lung parenchyma from sham (n = 5) and
PM10sum-treated mice (n = 5), 24 h after the third intratracheal instillation.
Sham vs. PM10sum-treated:
*p,0.05.
doi:10.1371/journal.pone.0056636.t002
Table 3. Immunoblotting analysis.
sham (n=6)
PM10sum
(n=6)
mean 6 s.e. mean 6 s.e. p
A- LUNG ET-1 1 0.1 1.69 0.52 *
HO-1 1 0.14 3.07 0.64 *
Hsp70 1 0.19 1.68 0.23 *
Cyp1B1 1 0.26 0.39 0.11 *
iNOS 1 0.14 0.75 0.08
MPO 1 0.24 1.32 0.32
Casp8-p18 1 0.24 1.04 0.15
Casp3-p17 1 0.32 1.1 0.2
pIRAK1/IRAK1 1 0.16 0.66 0.09
pTAK1/TAK1 1 0.24 1.21 0.12
pIKBa/IKBa 1 0.18 1.05 0.08
B- HEART ET-1 1 0.24 2.41 0.58 *
Cyp1B1 1 0.37 2.65 0.18 *
Hsp70 1 0.33 2.04 0.11 *
HO-1 1 0.44 1.5 0.27
MPO 1 0.26 2.45 0.11
Casp8-p18 1 0.27 1.02 0.14
Casp3-p17 1 0.34 0.72 0.22
C- BRAIN ET-1 1 0.2 2.86 0.86 *
HO-1 1 0.22 2.3 0.72 *
Cyp1B1 1 0.31 0.68 0.25
CD68 1 1.14 4.5 1.06
soluble TNF-a 1 0.24 2.22 0.36
memb TNF-a 1 0.2 1.19 0.41
Hsp70 1 0.2 1.17 0.28
GFAP 1 0.29 1.03 0.22
Casp8-p18 1 0.31 1.35 0.52
Casp3-p17 1 0.29 1.65 0.42
Immunoblotting analysis in lung (A), heart (B) and brain (C) parenchyma from
sham (n = 6) and PM10sum-treated mice (n = 6), 24 h after the third
intratracheal instillation. The proteins have been normalized to b-actin and each
protein in PM10-treated group has been normalized onto respective sham
group. All the data are expressed as mean 6 s.e. Sham vs. PM10sum-treated:
*p,0.05.
doi:10.1371/journal.pone.0056636.t003
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Discussion
Prolonged or persistent exposure to PM is supposed to exert
heavy adverse effects on cell homeostasis mediated by a direct
particles cell interaction within the district that PM reaches (lung,
myocardial or neuronal tissues), or by the induction of a chronic
inflammation, resulting in a general systemic inflammation and
sustained oxidative stress status [30].
In order to enhance the translocation of PM10sum we tested the
threshold able to lengthen the PM10sum pro-inflammatory effects
within lungs of our BALB/c mice. Previous published reports of
particles exposures that do not yield significant alterations in
markers of lung inflammation [31,32], but do show significant
changes in the expression of makers of inflammation and
endothelial activation in extra-pulmonary tissues, are basically
related to engine combustion derived particles. Indeed the
translocation of these fine particles might be quick enough to
directly exert systemic adverse effects even without overt
pulmonary effects.
Inflammatory Response Elicited by PM10sum in
Respiratory and Cardiovascular Systems
Lungs are the primary site of exposure to PM. In the BALf from
healthy mice, the alveolar macrophages are the most numerous
cells (.90%) and an influx of neutrophils is a sensitive indicator of
inflammatory reaction [28,29,33]. After three PM10sum intra-
tracheal instillations, differential cell count evidenced a significant
decrease of AMs percentage and a significant increase of PMNs
percentage. A compensatory effect between the infiltration of
PMNs and the extra-pulmonary migration of AMs is supposed to
take place, thus explaining the absence of difference of the total
cell count between sham and PM10sum-treated mice, as pre-
viously described [8].
Comparing to a single exposition [8], three repeated intra-
tracheal instillations of PM10sum showed a lower PMNs
percentage and a higher AMs percentage in the BALf of treated
mice, confirming that the acute inflammatory status is still
sustained but not heavily exacerbated, considering that the lung
clearance mechanisms are still working.
24 h after a single PM10sum instillation, TNF-a concentration
significantly increased in the BALf of treated mice [8]; neverthe-
less, 24 h after the last of three PM10sum instillations in a week
(cumulative dose of 0.3 mg/mice/week), TNF-a concentration
was basically unchanged comparing to sham. Moreover, histolog-
ical findings have not shown signs of lung particle overloading. All
together these observations claim for a mild ongoing lung
inflammation triggered by PM10sum treatment scheme. This
perfectly agree with the data coming from the extra-pulmonary
translocation of lung administered particles both in humans and
rodents [14,15,16,17,19,20,22,23].
Several chemoattractants derived from macrophages and
epithelial cells might be responsible for neutrophils recruitment
in the lung, in particular IL-1b [34]. 24 h after PM10sum
treatment, the significant increase of IL-1b concentration in the
BALf together with neutrophils infiltration suggests an ongoing
and persistent lung inflammation [35]. Indeed, the finding of
increased MIP-2 lung mRNA and BALf MIP-2 concentration
observed after 24 h in PM10sum-treated mice is in agreement
with the quick induction in MIP-2 mRNA observed in rat lungs
after in-vivo stimulation with IL-1b [34].
The increased MPO level in the BALf of PM10sum-treated
mice perfectly correlates with lung neutrophils infiltration: indeed,
MPO is an inflammatory marker released by degranulation of
activated neutrophils promoted by IL-1b [36,37] and its activity
increases after PM exposure [38].
The pro-inflammatory effect of PM with high LPS amount on
lungs of treated mice has been already described [39]. It is known
that mediators produced in the lungs are able to translocate into
the bloodstream [40] thus we analysed the presence of in-
flammatory markers also in blood and heart tissue of sham and
PM10sum-treated mice.
The lack of increase in circulating cytokines after acute particles
exposure might reflect that the PM induced inflammation is still
localized (i.e. confined to the lungs); however, after repeated PM-
exposure, the inflammatory cytokines released from lungs may
have enough time to enter the systemic circulation and become
detectable [41]. Indeed, the increased total cell number,
neutrophilia and high MPO levels, that we found in blood and
plasma of PM10sum-treated mice, support the hypothesis of
a systemic reaction and confirm the huge pro-inflammatory effect
of PM10sum.
Endothelial Activation in Lungs and Cardiovascular
System
An increase of vasoactive mediators may occur within the lungs
and the systemic circulation both in presence or absence of lung
inflammation [38]. Previous studies have shown that PM exposure
Table 4. Blood gene expression.
BLOOD fold increase range 6 s.e. p
HMOX1 2.21 1.00–5.37 0.95
IL-1b 1.23 0.52–2.39 0.66
miR-21 1.38 0.82–1.96 0.43
QPCR gene expression analysis in blood from sham (n = 5) and PM10sum-
treated mice (n = 5), 24 h after the third intratracheal instillation.
doi:10.1371/journal.pone.0056636.t004
Table 5. Blood/plasma analysis.
BLOOD sham (n=6)
PM10sum
(n=6)
mean 6 s.e. mean 6 s.e. p
A Total cells (cells/mm3) 4275 218.2 5718 454.91 *
Neutrophils (%) 5.3 0.86 14.9 1.37 **
sP-selectin (ng/mL) 78.12 3.98 97.98 3.02 *
TNF-a (pg/mL) n.d. n.d.
MIP-2 (pg/mL) n.d. n.d.
IL-1b (pg/mL) n.d. n.d.
B MPO 1 0.07 1.36 0.06 *
ET-1 1 0.15 2.18 0.35 *
Inflammation and coagulation markers have been analysed in blood/plasma of
sham and PM10sum-treated mice. (A): table summarizing assays in blood/
plasma from sham (n = 6) and PM10sum-treated mice (n = 6), 24 h after the
third intratracheal instillation; (B): immunoblotting results in plasma from sham
(n = 6) and PM10sum-treated mice (n = 6), 24 h after the third intratracheal
instillation. The proteins have been normalized to albumin and each protein in
PM10-treated group has been normalized onto respective sham group. All the
data are expressed as mean 6 s.e. Sham vs. PM10sum-treated:
*p,0.05;
**p,0.01.
doi:10.1371/journal.pone.0056636.t005
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is associated with an increases in ET-1 level in-vivo and in-vitro
[42,43].
In the lung parenchyma, the ET-1 expression in macrophages
as well as in endothelial and epithelial cells is stimulated by
cytokines, LPS, air pollutant and ozone [44,45]; ET-1 could
promote acute lung injury, inducing cytokines production and
activating neutrophils, releasing oxygen radicals [44]. Indeed, the
increased ET-1, that we found in the lungs of PM10sum-treated
mice, once more confirms an ongoing lung inflammation linked to
PM10sum exposure.
In the heart, ET-1 is synthesized by cardiomyocytes, fibroblasts,
and endothelial cells; moreover, ET-1 directly stimulates cardiac
fibroblasts to produce extracellular matrix proteins thus promoting
myocardial fibrosis [46]. The ET-1 expression has increased in
cardiac tissue of rats daily exposed to diesel exhaust particles and
to urban particulate matter [47]. Confirming previous findings,
the high ET-1 level observed in the heart of our PM10sum-treated
mice strengthens the evidences of cardiac adverse effects elicited
by PM10sum exposure.
A significant increase of ET-1 and sP-selectin were observed in
plasma of PM10sum-treated mice. As previously discussed, lung
cells may release ET-1 into the systemic circulation after PM
exposure, as well as the vascular ET system may be up-regulated
after PM exposure [38,48]. Increased levels of circulating ET-1
may trigger arterial vasoconstriction and influence the inflamma-
tory response by promoting the recruitment of leukocytes into
vessel walls [49]. High ET-1 within the plasma correlates with
acute coronary risk in concomitance to PM exposure [50].
Many data indicate that platelet adhesion to the endothelium is
an event preceding the development of atherosclerotic lesions [51],
contributing to the final stages of cardiovascular diseases [52]. sP-
selectin is a marker of activated interface blood-vasculature [53];
the significant increase in sP-selectin plasma concentration of
PM10sum-treated mice suggested a systemic endothelial activation
induced by PM10sum, which might be related to the high rate of
cardiovascular hospitalization following PM10 exposure peak.
Finally, high MPO levels that we found in blood of PM10sum-
treated mice could be related to an heavy endothelial dysfunction,
as discussed by Brook et al. [38]. The increase of MPO could be
potentially harmful, due to the generation of hypochlorous acid,
a compound toxic on bacteria and also onto host cells [37].
PM10sum Cytotoxic Effect in Lungs and Heart
A significant increase of LDH activity in the BALf was observed
24 h after the PM10sum third intratracheal instillation. However,
this evidence was not supported by any changes in ALP activity,
a specific marker of damage of type I pneumocytes and of
proliferation of type II pneumocytes [54]. The direct cytotoxic
damage induced by PM10sum might be basically related to AMs
and only marginally to pneumocytes, as previously we described
for winter PM [8]; it is possible to hypothesize that the damage
produced by repeated PM intratracheal instillations is a conse-
Figure 2. Lung histological analysis. Histology of lung tissue 24 h after the third intratracheal instillation. (A, B): lung parenchyma of sham mice,
showing bronchiolar and alveolar epithelia; (C, D): PM10sum-treated lung parenchyma, showing inflammatory cells recruitment and AMs infiltration
(arrows) in the connective surrounding terminal bronchioles and proximal alveolar sacs. Each figure represents the status evidenced examining 6
sham and 6 PM10sum-treated mice. A and C bars = 150 mm; B and D bars = 50 mm.
doi:10.1371/journal.pone.0056636.g002
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quence of the amounts of metals and PAHs still associated to
PM10sum.
The lung parenchyma necrosis and inflammation could explain
the increase of Hsp70 levels that we found in the BALf after
PM10sum instillation. Hsp70 might increase in the extracellular
milieu, where it acts as a cytokine to human monocytes [55], after
two events: an active release from epithelial cells or from
mononuclear cells and a passive release when cells undergo
necrosis [56].
Finally, in both lungs and heart, 24 h after the last PM10sum-
treatment, the initiator Caspase 8 and the effector Caspase 3 were
not active, despite the presence of pro-apoptotic inducers such as
cytokines and hypochlorous acid, eventually produced by MPO in
the BALf and blood, suggesting the existence of an on-going
protection mechanism.
HO-1 and Hsp70 Induced Protection in Lung and Heart
Parenchyma
HO-1 was significantly higher in the lungs of PM10sum-treated
mice thus indicating the existence of a protection mechanism
against oxidative stress and inflammation. In the lung parenchy-
ma, HO-1 is expressed in various cells, including type II
pneumocytes and AMs [57]. Its role is to catabolize the heme
group from the cytosol, thus generating CO, biliverdin (converted
to bilirubin) and Fe2+ thus playing a protective role against
inflammation and oxidative stress [58]. Moreover, it has been
hypothesized the existence of a post-translational down-regulation
of cytochromes following the induction of HO-1, possibly related
to a decrease in the heme group bioavailability [59]. Consistently
with this observations, we found a significant decrease in Cyp1B1
levels in the lung parenchyma of PM10sum-treated mice.
On the contrary, the absence of a significant increase of HO-1
in the heart of PM10sum-treated mice allows the increase of
Cyp1B1, thus suggesting that soluble molecules PM-related could
reach the heart parenchyma through the bloodstream.
Oxidative stress, LPS, cytokines, ER stress and protein
unfolding induced by PM exposure, might promote the expression
of heat shock proteins, such as Hsp70 or Hsp90 [60]; in particular,
the intracellular Hsp70 has the ability to protect cells and tissues
limiting the amount of inflammatory mediators [61]. In both lung
and heart parenchyma, Hsp70 showed a significant increase 24 h
after the last PM10sum instillation, suggesting that the active
protection system is not only related to the induction of HO-1.
Graff et al. [62] demonstrated that the treatment of rat ventricular
myocytes with Zn and V induced small but significant increases in
the expression of Hsp70. Taking into account that Zn and V are
soluble components PM-related and have the potential to be
absorbed into the bloodstream and transported to the heart
[62,63], we hypothesize that these two metals could be in part
accountable of the Hsp70 increase that we observed in PM10sum-
treated mice.
Figure 3. Lung immunohistochemical analysis. Immunohistochemical analyses of HO-1 expression in lung tissue 24 h after the third
intratracheal instillation; the brown color reflects the site and intensity of HO-1 expression. (A): lung of sham mice; in the box, a control of the
immunohistochemical reaction specificity, where the primary antibody has been avoided, in a PM10sum instilled mouse; (B): alveolar and
peribronchiolar spaces in the lung of a sham mouse; (C, D): alveolar and peribronchiolar spaces in lungs of PM10sum-treated mice. Each figure
represents the status evidenced examining 6 sham and 6 PM10sum-treated mice. A bar = 150 mm; B–D bars = 50 mm.
doi:10.1371/journal.pone.0056636.g003
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Finally, both Hsp70 and HO-1, are important apoptotic
inhibitors [64,65] which might thus explaining the absence of
apoptosis cascade activation that we found in lungs and heart
parenchyma of PM10sum treated mice.
miR-21
In order to advance our studies on the PM10sum toxic effects,
we considered a new class of molecules, miRNAs. In particular,
according to literature, miR-21 is one of the miRNAs induced in
mice lungs by exposure to LPS [66] and is involved in negative
regulation of the signalling pathway of TLR-2 [67] and TLR-4
[11], thus playing a key role in orchestrating the inflammatory
process induced by LPS. Moschos et al. [66] and Sheedy et al.
[11] have hypothesized that miR-21 might be involved in the
resolution rather than in the induction of inflammation. So,
increased miR21 levels that we found in the lungs of PM10sum-
treated mice could be considered a marker of inflammatory status
associated to an ongoing protection reaction. Consistent with this
observation, the TLR4 pathway was not activated in the lungs of
PM10sum-treated mice.
PM10sum Toxicity on Brain
The BBB endothelial cells play an essential role in maintaining
brain homeostasis, actively transporting nutrients, and limiting the
entrance to harmful components such as LPS and cytokines [68].
In healthy brain, the endothelial cells express very low levels of
adhesion molecules required for leukocyte migration [69], and
expression of ET-1 increases BBB permeability in-vivo [68]. Guo
et al. [35] proposed that elevated plasma levels of ET-1, induced
by PM10 exposure in-vivo, may promote ET-1 penetration within
the brain either by active transport or by passive diffusion across
a permeabilized BBB. The high ET-1 levels that we found in the
brains of PM10sum-treated mice suggest a compromised BBB
function [7], therefore allowing the translocation of smallest
particles and/or of their soluble components within brain. It has
been disclosed that ET-1 is a key factor in the development of
PM10-mediated brain endothelial injury.
A possible mechanism by which PM exerts its toxic effect on
brain cells has been proposed by Block et al. [70]: it is supposed
that particles might initiate the phagocytic activity of microglia,
leading to the neurotoxic production of extracellular superoxide.
As neurons are particularly vulnerable to oxidative damage, the
ROS production can lead to neuron death. In our investigations,
PM10sum-treatment causes an increase in brain HO-1 levels,
probably as a consequence of oxidative stress induction.
The chronic induction of HO-1 can have both beneficial and
detrimental effects on cellular metabolism. While exists plenty of
evidence for the HO-1-mediated neuro-protection, a growing
literature attesting the neuro-endangering effects of HO-1 activity
is also at hand [71]. Fe2+ produced by HO-1 can catalyze the
production of free radicals through the Fenton’s chemistry, thus
acting as a cytotoxic and oxidative stress inducer. Indeed, the
excessive cellular amounts of free Fe2+ heme-derived resulting
from HO-1 over-activity and dysregulation of iron metabolism
[72] may be related to the pathogenesis of neuro-degenerative
disorders [73].
Finally, it must be noted that the intratracheal administration
route for PM has completely avoided the particles transport along
the olfactory nerve. Alterations in the nasal mucosa, olfactory
bulb, cortical and sub-cortical brain structures have been de-
scribed in healthy dogs exposed to high levels of ambient air
pollutants [74]; in addition, brain biomarkers of oxidative stress
and tissue injury have been observed in mice exposed to
concentrated ambient particles [75]. Indeed, it is possible that
ET-1 and HO-1 increased levels in the brain of our PM10sum-
treated mice could be attenuated, while PM nasal inhalation could
induce higher oxidative stress and endothelial activation in some
regions of the central nervous system.
Conclusions
A repeated exposure of PM10sum in BALB/c mice leads to the
induction of lungs inflammation, associated to cytokine pro-
duction, PMNs infiltration and endothelium activation. Trans-
location of mediators, cytokines, ultrafine particles, LPS and/or
metals associated to PM10sum from lungs to bloodstream triggers
systemic adverse effects, involving heart and brain. The activation
of endothelium/platelets interface that we found in PM10 exposed
mice could explain the associations between short-term induced
changes by inhalable particles and cardiovascular hospital
admissions. Our results confirm the systemic toxic effect triggered
by PM10sum mainly involving the respiratory and cardiovascular
system in an inflammatory and pro-coagulant reaction, thus
intending a correlation between PM exposure and cardiovascular
diseases. However, lungs and heart might activate some putative
protection mechanisms against inflammation and/or cytotoxicity
thus supporting that compensatory mechanisms may occur within
sub acute PM exposure.
PM10sum promotes brain endothelial activation and oxidative
stress induction. In recent years, increasing evidences indicates
Alzheimer and other neurodegenerative diseases at least partially
mediated by oxidative stress and impaired BBB functions.
These findings may contribute to the knowledge of the interplay
between PM exposure and cardiovascular diseases, the chronic
oxidative stress generation and the development of neurodegen-
erative diseases. Future investigations should address the effects of
lifetime air pollution exposure and aging related to the neuroin-
flammation and to the neurotoxicity.
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